Hanan Georgey

Dr. Hanan Georgey


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2008 in Molecules
Verified
Journal Article
Open access
PDF file
HGHanan Georgey
Hanan Georgey
NANagwa Abdel-Gawad
Nagwa Abdel-Gawad
SASafinaz Abbas
Safinaz Abbas
A number of 3-substituted-2-(substituted-phenoxymethyl) quinazolin-4(3H)-one derivatives 4a,b, 5a-c, 6, 7a-f, 8a-e and 9a,b have been synthesized. Their structures have been elucidated on the basis of elemental analyses and spectroscopic studies (IR, 1H-NMR, MS). A preliminary evaluation of the anticonvulsant activity of the prepared compounds has indicated that compounds 4b, 7b-f, 8a and 9b exhibit significant anticonvulsant activity, while compounds 6, 8b and 8d show mild to moderate activity.

27 February 2011 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
AGAbd-El Gawad
Abd-El Gawad
NMNagwa M.
Nagwa M.
GHGhaneya S. Hassan
Ghaneya S. Hassan
HGHanan Georgey
Hanan Georgey

24 October 2010 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
NGNagwa M. Abdel Gawad
Nagwa M. Abdel Gawad
HGHanan Georgey
Hanan Georgey
RYRiham M. Youssef
Riham M. Youssef
NSNehad A. El Sayed
Nehad A. El Sayed

29 May 2012 in Archives of Pharmacal Research
Verified
Journal Article
Closed access
PDF file
NGNagwa M. Abd-El Gawad
Nagwa M. Abd-El Gawad
HGHanan Georgey
Hanan Georgey
NINashwa A. Ibrahim
Nashwa A. Ibrahim
NANoha H. Amin
Noha H. Amin
RARania M. Abdelsalam
Rania M. Abdelsalam

13 December 2017 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
GHGhaneya S Hassan
Ghaneya S Hassan
HGHanan Georgey
Hanan Georgey
RGRiham F George
Riham F George
EMEman R Mohammed
Eman R Mohammed
Aim: In spite of the availability of different chemotherapies for cancer treatment, there is still a need for new candidates with higher efficacy and lower toxicity. Methodology: Aurones 7a–f, 8a–f and furoaurones 13a–f, 16a–c were synthesized. Some compounds were selected by the National Cancer Institute, USA, for cytotoxicity screening. Results & discussion: The furoaurone derivative, 13a was the most active one exhibiting promising growth inhibition against leukemia, K562 and melanoma, MDA-MB-435 cells at concentration of 10 μM. It induced apoptosis in both cell lines by activation of CASP3 and inhibition of CDK2. Additionally, 13a showed good selectivity over normal kidney and liver cells. Simulation docking study was undertaken to gain insight into the possible binding mode of 13a in the CDK2 enzyme. Conclusion: The furoaurone 13a can be considered as a scaffold for further optimization to obtain more active hits. Graphical abstract

6 February 2011 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
AGAbdel Gawad
Abdel Gawad
NMNagwa M.
Nagwa M.
GHGhaneya S. Hassan
Ghaneya S. Hassan
HGHanan Georgey
Hanan Georgey
HEHesham Y. El-Zorba
Hesham Y. El-Zorba